Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ole Søgaard and Jesper Højen.
Ole Søgaard
Connection Strength
0.410
Jesper Højen
  1. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine. 2021 May; 35:100849.
    View in: PubMed
    Score: 0.235
  2. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity. EBioMedicine. 2021 Jun; 68:103410.
    View in: PubMed
    Score: 0.059
  3. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021 Feb; 64:103230.
    View in: PubMed
    Score: 0.058
  4. Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety. Basic Clin Pharmacol Toxicol. 2021 Feb; 128(2):204-212.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.